ORLANDO—New studies support the use of active surveillance (AS) for selected patients with localized, low-risk prostate tumors.

Focal therapy with high-intensity focused ultrasound (HIFU) of localized prostate cancer provides immediate cancer control, comparable to that of other treatment modalities, according to Japanese researchers.

DENVER—Close surgical margins in radical prostatectomy specimens could place patients at increased risk of PSA failure, according to a study that may challenge conventional wisdom.

DENVER—The presence of tumor cells at the end of a needle biopsy core obtained near the capsule is an independent indicator of a significantly elevated risk of extracapsular extension, according to data presented here at the annual meeting of the United States and Canada Academy of Pathology.

THE PROSTATE cancer gene 3 (PCA3) urine test is superior to percent-free PSA in predicting prostate biopsy outcome, according to researchers.

HIGH-GRADE tumors are more likely to be found in smaller prostates, according to researchers in Spain.

A European study revealed no link between dietary fat intake and the risk of prostate cancer, according to a report in the American Journal of Clinical Nutrition (2008;87:1405-1413).

SAN DIEGO—Genetic analyses suggest that prostate cancer in African-American men is distinctly different as compared with European-American men, according to researchers at the National Cancer Institute (NCI) in Bethesda, Md.

High-intensity focused ultrasound (HIFU), a minimally invasive treatment for localized prostate cancer, achieves effective long-term disease control in patients with low- and intermediate-risk tumors, according to researchers in France and Germany.

ORLANDO, Fla.—External beam radiation therapy (EBRT) increases the risk of secondary malignancies relative to radical prostatectomy in men with localized prostate cancer, data show.